Pay in 4 interest-free payments of $6.43 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
GLP-1 Agonists Show Promise in Treating Substance Use Disorders Nov 7, 2025 5 min read Updated: Dec 17, 2025 In recent years, medications originally developed to treat Type 2 diabetes, obesity, and other weight-related conditionssuch as semaglutide and liraglutideare showing promise in treating substance use disorders (SUDs)
Plus, berberine can help lower cholesterol, improve gut health, and reduce inflammation
Taoufik et al., 2021
These combine to minimize irritation while amping up antioxidant protection and ingredient stability. Thats how you get to a 25% Vitamin C concentration without risk of irritation
The safety data from animal studies is reassuring
US$ 29.02
US$ 28.89
US$ 19.99
US$ 20.08
US$ 26.34
US$ 27.28
US$ 25.31
US$ 29.59
US$ 24.23
